SEC Form 5 · accession 0001012975-18-000164
Syros Pharmaceuticals, Inc. · SYRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Noubar Afeyan
10% Owner
Period of report
Dec 31, 2017
Accepted (ET)
Feb 13, 2018 · 6:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001556263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 8, 2017 | G | 24,527 | $0.00 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.